Alana McNulty

Chief Financial Officer

Alana McNulty has served as our Chief Financial Officer since July 2012. Ms. McNulty served in such role as a consultant until October 2015, when she became an employee. Prior to joining eFFECTOR as an employee, Ms. McNulty also served as Chief Financial Officer of Lumena Pharmaceuticals Inc., a biopharmaceutical company, from July 2012 until its acquisition by Shire plc in November 2014, and as Chief Financial Officer of Excaliard Pharmaceuticals, Inc., a biopharmaceutical company, from March 2011 through its acquisition by Pfizer Inc. in November 2011. Previously, Ms. McNulty was acting Chief Financial Officer at BrainCells, Inc., a biopharmaceutical company, from 2004 until 2011 and Chief Financial Officer of Elitra Pharmaceuticals Inc., a biopharmaceutical company, from 1998 to 2003. Prior to that Ms. McNulty was head of Corporate Development and a General Manager of a business unit at Advanced Tissue Sciences. Ms. McNulty received a B.A. in Biology with High Honors from the University of California, Santa Barbara and an M.B.A. from the Anderson School of Business at the University of California, Los Angeles.